Form 4: BlackRock BTX Director Sells Shares

Sentiment:

Insider Transaction Report


BlackRock Technology & Private Equity Term Trust Director Robert W. Fairbairn reported the sale of common stock under a Rule 10b5-1 trading plan.

Summary

  • Robert W. Fairbairn, a Director of BlackRock Technology & Private Equity Term Trust (BTX), reported the sale of common stock.
  • The transactions were made pursuant to a pre-arranged Rule 10b5-1 trading plan, indicating they were scheduled in advance.
  • On December 18, 2025, Fairbairn sold 21,936 shares of common stock at a price of $6.52 per share.
  • On December 19, 2025, Fairbairn sold an additional 0.7067 shares of common stock at a price of $6.55 per share.
  • Following these transactions, Fairbairn beneficially owns 0 shares of BlackRock Technology & Private Equity Term Trust common stock.

Sentiment

Score: 6

Explanation: The reported sales are part of a pre-arranged Rule 10b5-1 trading plan, which indicates the transactions were scheduled in advance and not based on recent non-public information. This mitigates the typical negative sentiment associated with insider selling, moving the sentiment towards neutral.

Positives

  • The sales were conducted under a Rule 10b5-1 plan, which suggests the transactions were pre-scheduled and not based on recent non-public information, mitigating typical negative interpretations of insider selling.

Negatives

  • A director has divested their entire direct beneficial ownership in the company's common stock, which could be perceived as a lack of future confidence by some investors.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

  • Shareholders may interpret the director's complete divestment of direct holdings as a signal, though the 10b5-1 plan context reduces its immediate negative impact.

Key Dates

DateDescription
12/18/2025Sale of 21,936 shares of common stock at $6.52 per share by Robert W. Fairbairn.
12/19/2025Sale of 0.7067 shares of common stock at $6.55 per share by Robert W. Fairbairn.
12/22/2025Date the Form 4 was signed and filed.

Recommendation

hold

The director's sale of shares was executed under a pre-arranged Rule 10b5-1 plan, suggesting the transactions were scheduled independently of current market conditions or non-public information. This reduces the typical negative implications of insider selling, warranting a 'hold' recommendation as it does not provide new fundamental insights for a 'buy' or 'sell' decision.

Keywords

BlackRock Technology & Private Equity Term Trust, BTX, Insider Trading, Form 4, Stock Sale, Director, Robert W. Fairbairn, 10b5-1 Plan

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.